Role of hepatocyte plasma membrane in insulin degradation
- PMID: 3881987
- DOI: 10.1152/ajpendo.1985.248.2.E194
Role of hepatocyte plasma membrane in insulin degradation
Abstract
An important role of the cell membrane in insulin degradation by cultured rat hepatocytes is supported by studies using the surface-active antibiotic bacitracin. Bacitracin inhibited degradation of cell-associated insulin (both randomly and A14 labeled) by 80-90% at 15 degrees C and by 60% at 37 degrees C. At 37 degrees C, inhibition of degradation was observed only with bacitracin present during dissociation and was accompanied by a compensatory increase in release of trichloroacetic acid (TCA)-precipitable insulin. This profile suggests inhibition of insulin degradation on the membrane after either primary binding or diacytosis (endocytosis-reverse endocytosis). In contrast, at 15 degrees C, bacitracin's inhibitory effect was greater with the antibiotic present during association and was not accompanied by a compensatory increase in TCA-precipitable insulin. This profile was compatible with inhibition of partial cleavage of insulin on the membrane. Internalization and degradation through chloroquine-sensitive pathways may be required to complete degradation at this temperature because chloroquine exhibited an inhibitory effect on insulin degradation equally potent to that of bacitracin at 15 degrees C (no effect at 37 degrees C).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
